| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/30/2007 | CA2637573A1 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives |
| 08/30/2007 | CA2635472A1 Soluble receptors and methods for treating autoimmune or demyelinating diseases |
| 08/30/2007 | CA2626100A1 Treatment for antiphospholipid-syndrome-related pregnancy complications |
| 08/29/2007 | EP1826218A1 Antihuman baff antibody |
| 08/29/2007 | EP1826217A1 Method for identification of antigenic peptides |
| 08/29/2007 | EP1826207A1 Acid salt of benzimidazole derivative and crystal thereof |
| 08/29/2007 | EP1825863A1 Recombinant porcine adenovirus vector |
| 08/29/2007 | EP1825850A1 Use of resveratrol and derivatives thereof for promoting the wellness state in mammals |
| 08/29/2007 | EP1824887A2 Cytotoxic antibody directed against type b lymphoid hematopoietic proliferations |
| 08/29/2007 | EP1824818A2 2ALFA-METHYL AND 2ß-METHYL ANALOGS OF 19,26,27-TRINOR-(20S)-1ALFA-HYDROXYVITAMIN D3 AND THEIR USES |
| 08/29/2007 | EP1824514A2 Toll like receptor 3 antagonists, methods and uses |
| 08/29/2007 | EP1725538B1 Pyridazinone ureas as antagonists of a4 integrins |
| 08/29/2007 | EP1562938B1 Heteroaryl-pyrimidine derivatives as jak inhibitors |
| 08/29/2007 | EP1450847A4 Apo2 ligand/trail formulations |
| 08/29/2007 | EP1404652B1 A novel alkaloid derivative and a pharmaceutical composition containing the same |
| 08/29/2007 | EP1351934B1 Naphthalene derivatives which bind to the ep4 receptor |
| 08/29/2007 | EP1333840B9 M. tuberculosis chaperonin 60.1 and uses thereof |
| 08/29/2007 | EP1268431B1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 08/29/2007 | EP1165781B1 Protease resistant flint analogs |
| 08/29/2007 | EP0910635B1 Hematopoietic cytokine receptor |
| 08/29/2007 | EP0763059B1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments |
| 08/29/2007 | CN200939251Y Se-garlic capsules |
| 08/29/2007 | CN101027302A Pyrrolo-pyridine kinase modulators |
| 08/29/2007 | CN101027100A Method for treating sjogren's syndrome |
| 08/29/2007 | CN101027084A Mutated HIV NEF for modulating immunity |
| 08/29/2007 | CN101027069A 神经酰胺酶抑制剂 Ceramidase inhibitor |
| 08/29/2007 | CN101027049A A pharmaceutical composition and its use |
| 08/29/2007 | CN101027048A Medicinal composition as immunosuppressant |
| 08/29/2007 | CN101024831A A tumor necrosis factor related ligand |
| 08/29/2007 | CN101024671A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 08/29/2007 | CN101024071A Thymopentin injecta liquid formulation |
| 08/29/2007 | CN101024056A Method for preparing toxin-reducing bacteria vaccine for domestic animals, fowls |
| 08/29/2007 | CN101024047A 3-D incense therapy rod |
| 08/29/2007 | CN101024035A Oral Chinese medicine composition for treating urtica |
| 08/29/2007 | CN101023987A Medicine for treating allergic rhinitis |
| 08/29/2007 | CN101023975A Composition containing effective parts of astragalus root and Acanthopanx senticosusharm and its use thereof |
| 08/29/2007 | CN101023969A Hippophate flavone powder capsule and its preparing method |
| 08/29/2007 | CN101023963A Method for preparing natural astaxanthin and fishliver oil |
| 08/29/2007 | CN101023958A Buccal tablet of Asraguluspolysacharin |
| 08/29/2007 | CN101023949A Loratadine dispersible tablets and its preparing method |
| 08/29/2007 | CN101023946A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 08/29/2007 | CN101023772A Gastrodia-walnut health-care sweet |
| 08/29/2007 | CN101023765A Gastrodia tuber health-care tea |
| 08/29/2007 | CN101023764A Chrysanthemum epidermic-prevention pharynt-clearing tea and preparing method |
| 08/29/2007 | CN100334228C Cimeric immunomodulatory compounds and methods of using the same |
| 08/29/2007 | CN100334106C Synthesis of cyclosporin analogs |
| 08/29/2007 | CN100334093C Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 08/29/2007 | CN100333794C Adjuvanted genetic vaccines |
| 08/29/2007 | CN100333792C Rsv基因表达疫苗 Rsv gene expression vaccine |
| 08/29/2007 | CN100333787C YG and YGG used as maintenance and improvement of immunoreaction |
| 08/29/2007 | CN100333778C Chinese medicine for treating cancer |
| 08/29/2007 | CN100333713C Method for preparing milk contg. micron sugared-ginseng and bee-glue for tonifying-Yin and lowering blood-sugar |
| 08/28/2007 | US7262309 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1 |
| 08/28/2007 | US7262286 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 08/28/2007 | US7262277 Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 08/28/2007 | US7262274 Kit which detects ligand associated with nuclear factor kappa beta receptor for treating toxic shock, sepsis, inflammation and graft vs host disease |
| 08/28/2007 | US7262201 Quinazoline derivatives |
| 08/28/2007 | US7262193 Triazaspiro[5.5]undecane derivative and pharmaceutical composition comprising the same as active ingredient |
| 08/28/2007 | US7262187 Substituted oxazolo- and thizaolopyrimidinones as a mitotic kinesin inhibitor |
| 08/28/2007 | US7262180 For therapy of dermatitis conditions and skin impairments such as atopic dermatitis, contact dermatitis, allergic contact dermatitis, allergic dermatitis, seborrheic dermatitis, nummular dermatitis, chronic dermatitis of hands or feet, generalized exfoliative dermatitis, stasis dermatitis |
| 08/28/2007 | US7262050 Humanised antibodies |
| 08/28/2007 | US7261896 Methods for preventing strokes by inducing tolerance to e-selectin |
| 08/28/2007 | US7261890 Methods for using canine immunoglobulin variable domains and caninized antibodies |
| 08/28/2007 | CA2264693C Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation |
| 08/28/2007 | CA2257875C Topical administration of certain azaspiranes to prevent or treat skin conditions associated with hyperproliferation of skin cells and/or immunologically mediated disorders |
| 08/28/2007 | CA2193553C Method for treatment of lupus nephritis |
| 08/28/2007 | CA2184727C Proteasome regulation of nf-kb activity |
| 08/28/2007 | CA2148253C Allergenic proteins and peptides from johnson grass pollen |
| 08/28/2007 | CA2125763C P40 homodimer of interleukin-12 |
| 08/28/2007 | CA1341538C Dna encoding ige receptor alpha-subunit or fragment thereof |
| 08/23/2007 | WO2007094462A1 Non-human animal having modified genome or offspring thereof |
| 08/23/2007 | WO2007094360A1 Process for producing polysaccharide from coffee bean or/and coffee extraction residue |
| 08/23/2007 | WO2007094137A1 Method of inducing cytotoxic t-cell, cytotoxic t-cell inducer and, produced therewith, pharmaceutical composition and vaccine |
| 08/23/2007 | WO2007093346A1 High dosage of mycophenolic acid (mpa) |
| 08/23/2007 | WO2007071839A3 Potentiation of apoptosis by monoclonal antibodies |
| 08/23/2007 | WO2007068473A3 Organic compounds |
| 08/23/2007 | WO2007039150A3 Cell populations having immunoregulatory activity, method for isolation and uses |
| 08/23/2007 | WO2002097035A3 Secreted proteins |
| 08/23/2007 | US20070197829 Process for the synthesis and crystalline form agomelatine |
| 08/23/2007 | US20070197648 Pharmaceutical product containing tranilast |
| 08/23/2007 | US20070197644 Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 08/23/2007 | US20070197589 Cyclic quaternary amino derivatives as modulators of chemokine receptors |
| 08/23/2007 | US20070197587 Quinoline Derivatives as CRTH2 Antagonists |
| 08/23/2007 | US20070197570 Indanol derivative |
| 08/23/2007 | US20070197561 Inhibitors of nucleoside metabolism |
| 08/23/2007 | US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome |
| 08/23/2007 | US20070197547 4-(1-piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-(1-piperazinyl)-1-methyl-3-nitro-2(1H)-quinolone |
| 08/23/2007 | US20070197510 Nitriles and medicinal compositions containing the same as the active ingredient |
| 08/23/2007 | US20070197503 Solutions containing epinastin |
| 08/23/2007 | US20070197499 Pharmaceutical compounds |
| 08/23/2007 | US20070197489 Composition of matter |
| 08/23/2007 | US20070197476 Triptolide Derivatives And Their Uses |
| 08/23/2007 | US20070197434 Theurapeutic or prophyiactic agent for arthritis |
| 08/23/2007 | US20070197428 Novel indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals |
| 08/23/2007 | US20070196922 Methods and Compositions Relating to Restricted Expression Lentiviral Vectors and Their Applications |
| 08/23/2007 | US20070196445 Method for the Prevention and Treatment of Cachexia and Anorexia |
| 08/23/2007 | US20070196394 Immunogenic compositions comprising Liver Stage Malarial Antigens |
| 08/23/2007 | US20070196370 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/23/2007 | US20070196369 MHC-peptide complex binding ligands |
| 08/23/2007 | US20070196331 Methods and compositions for mobilizing stem cells |